Immunos Therapeutics
Series CImmunos Therapeutics raised €9.9M in a Series C round in Sep 2024. The company is based in Schlieren, Switzerland. Investors in the round: BioMedPartners, Double Point Ventures, GIMV and 2 others. Data as of Nov 2026.
Amount raised
€9.9M
€9,888,529
Native amount
11,000,000 USD
Stage
Series C
series c
Investors
5
Provenance & confidence
High confidenceAmount
11,000,000 USD
ECB-at-date → €9.9M · rate 1.1124 on 2024-09-18
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedDate
Sep 2024
Round type
series c
Amount (EUR)
€9.9M